Chemed Corporation (NYSE: CHE) reported Q2 EPS of $2.81, $0.04 better than the analyst estimate of $2.77. Revenue for the quarter came in at $442 million versus the consensus estimate of $434.27 million.

GUIDANCE:

Chemed Corporation sees FY2018 EPS of $11.35-$11.55.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.